Kyobo 8 Special Purpose Acquisition Company (307280) - Total Assets
Based on the latest financial reports, Kyobo 8 Special Purpose Acquisition Company (307280) holds total assets worth ₩49.65 Billion KRW (≈ $33.65 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Kyobo 8 Special Purpose Acquisition Comp (307280) stock price for real-time trading data and today's change.
Kyobo 8 Special Purpose Acquisition Company - Total Assets Trend (2022–2025)
This chart illustrates how Kyobo 8 Special Purpose Acquisition Company's total assets have evolved over time, based on quarterly financial data. Also see Kyobo 8 Special Purpose Acquisition Comp (307280) cash conversion ratio for how efficiently the company converts equity into cash flow.
Kyobo 8 Special Purpose Acquisition Company - Asset Composition Analysis
Current Asset Composition (December 2025)
Kyobo 8 Special Purpose Acquisition Company's total assets of ₩49.65 Billion consist of 56.8% current assets and 43.2% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 17.3% |
| Accounts Receivable | ₩5.35 Billion | 11.2% |
| Inventory | ₩5.90 Billion | 12.4% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩395.44 Million | 0.8% |
| Goodwill | ₩151.98 Million | 0.3% |
Asset Composition Trend (2022–2025)
This chart illustrates how Kyobo 8 Special Purpose Acquisition Company's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Kyobo 8 Special Purpose Acquisition Comp working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Kyobo 8 Special Purpose Acquisition Company's current assets represent 56.8% of total assets in 2025, an increase from 46.8% in 2022.
- Cash Position: Cash and equivalents constituted 17.3% of total assets in 2025, up from 8.3% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 2.0% in 2022.
- Asset Diversification: The largest asset category is inventory at 12.4% of total assets.
Kyobo 8 Special Purpose Acquisition Company Competitors by Total Assets
Key competitors of Kyobo 8 Special Purpose Acquisition Company based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Winner Medical Co Ltd
SHE:300888
|
China | CN¥18.48 Billion |
|
Autek China Inc
SHE:300595
|
China | CN¥6.40 Billion |
|
Guangzhou Jet Bio-Filtration Co Ltd
SHG:688026
|
China | CN¥1.72 Billion |
|
Bio-gate AG
XETRA:BIG1
|
Germany | €3.95 Million |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
Kyobo 8 Special Purpose Acquisition Company - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.31 | 5.15 | 5.15 |
| Quick Ratio | 3.31 | 3.93 | 3.93 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩19.09 Billion | ₩18.82 Billion | ₩18.82 Billion |
Kyobo 8 Special Purpose Acquisition Company - Advanced Valuation Insights
This section examines the relationship between Kyobo 8 Special Purpose Acquisition Company's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.89 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 15.4% |
| Total Assets | ₩47.63 Billion |
| Market Capitalization | $28.61 Million USD |
Valuation Analysis
Below Book Valuation: The market values Kyobo 8 Special Purpose Acquisition Company's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Kyobo 8 Special Purpose Acquisition Company's assets grew by 15.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Kyobo 8 Special Purpose Acquisition Company (2022–2025)
The table below shows the annual total assets of Kyobo 8 Special Purpose Acquisition Company from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩47.63 Billion ≈ $32.28 Million |
+15.40% |
| 2024-12-31 | ₩41.27 Billion ≈ $27.97 Million |
-3.81% |
| 2023-12-31 | ₩42.90 Billion ≈ $29.08 Million |
+10.20% |
| 2022-12-31 | ₩38.93 Billion ≈ $26.38 Million |
-- |
About Kyobo 8 Special Purpose Acquisition Company
Wonbiogen Co., Ltd. manufactures and sells wound dressings in South Korea, rest of Asia, Europe, and internationally. It operates through Wound Dressing and Daily Necessities divisions. The company offers polyurethane foam and hydrocolloid dressings; cosmetics; other dressings; and daily necessities. It also provides medical, organic, and inorganic materials; and laundry detergents. Wonbiogen Co.… Read more